Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$1.65M
6.46K shares
What this filing means
HAAS JASON plans to sell 6.46K shares of LIGAND PHARMACEUTICALS INC valued at approximately $1.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001950047-26-005992
6.46K
Shares to sell
$1.65M
Approx. market value
6.46K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
6/12/2026
4KRestricted Stock
Not Applicable
6/5/2026
1.21KRestricted Stock
Not Applicable
6/6/2025
1.25KTotal acquired6.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2026 | Stock Option Exercise Cash | 4K | — |
6/5/2026 | Restricted Stock Not Applicable | 1.21K | — |
6/6/2025 | Restricted Stock Not Applicable | 1.25K | — |
| Total | 6.46K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.46K
Market value
$1.65M
6/12/2026
Total
Units
6.46K
Value
$1.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2026 | 6.46K | $1.65M | NASDAQ | Planned |
| Total | 6.46K | $1.65M | ||